DE BACKER MARIANNE (Chief Executive Officer) sold 1.4% of their position (14.76K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $140.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001628280-26-012390
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-14.76K
Net shares
Net seller
$140.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.76K
Price / share
$9.53
Trade value
$140.72K
% of position
1.4%
2/24/2026
1.04M→1.02M
Total
Net shares
−14.76K
Net value
-$140.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −14.76K | $9.53 | $140.72K | 1.4% | 1.04M | 1.02M |
| Total | −14.76K | -$140.72K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned53.12K
Total
53.12K indirect53.12K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 53.12K | Indirect |
| Total | 53.12K | 53.12K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported